| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ELOVL4 ADORA1 OR2B11 GIPR TAS2R3 OR8J2 ADRA2B CSF1R MCHR1 PTPRF P2RY1 PLXNC1 OR10P1 CXCR4 GLP1R GLRA1 GPR173 AGTR1 GLRA3 GPR84 IL20RA LTB4R ADGRV1 OR2B6 ADGRA2 | 9.57e-14 | 1353 | 63 | 25 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | ELOVL4 ADORA1 OR2B11 GIPR TAS2R3 OR8J2 ADRA2B MCHR1 P2RY1 OR10P1 CXCR4 GLP1R GPR173 AGTR1 GPR84 LTB4R ADGRV1 OR2B6 ADGRA2 | 1.51e-11 | 884 | 63 | 19 | GO:0004930 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 3.88e-06 | 133 | 63 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 5.22e-06 | 140 | 63 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.99e-05 | 296 | 63 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC7A9 KCNH6 MFSD2A SLC26A8 ABCA2 SLC24A2 SLC22A14 SLC15A4 GLRA1 SLC19A3 GLRA3 SLC45A2 SLC24A1 | 6.59e-05 | 1180 | 63 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 9.74e-05 | 5 | 63 | 2 | GO:0008273 | |
| GeneOntologyMolecularFunction | symporter activity | 1.11e-04 | 150 | 63 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.22e-04 | 477 | 63 | 8 | GO:0022804 | |
| GeneOntologyMolecularFunction | acylglycerol O-acyltransferase activity | 1.39e-04 | 32 | 63 | 3 | GO:0016411 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 1.46e-04 | 6 | 63 | 2 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 1.46e-04 | 6 | 63 | 2 | GO:0016934 | |
| GeneOntologyMolecularFunction | transporter activity | SLC7A9 KCNH6 MFSD2A SLC26A8 ABCA2 SLC24A2 SLC22A14 SLC15A4 GLRA1 SLC19A3 GLRA3 SLC45A2 SLC24A1 | 1.61e-04 | 1289 | 63 | 13 | GO:0005215 |
| GeneOntologyMolecularFunction | diacylglycerol O-acyltransferase activity | 2.71e-04 | 8 | 63 | 2 | GO:0004144 | |
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 2.71e-04 | 8 | 63 | 2 | GO:0005237 | |
| GeneOntologyMolecularFunction | hormone binding | 3.15e-04 | 103 | 63 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.19e-04 | 293 | 63 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 3.69e-04 | 301 | 63 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 4.34e-04 | 10 | 63 | 2 | GO:0005432 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.92e-04 | 207 | 63 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.03e-04 | 208 | 63 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | KCNH6 MFSD2A SLC26A8 SLC24A2 SLC15A4 GLRA1 GLRA3 SLC45A2 SLC24A1 | 5.89e-04 | 758 | 63 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 7.47e-04 | 13 | 63 | 2 | GO:0015368 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | KCNH6 MFSD2A SLC26A8 SLC24A2 SLC15A4 GLRA1 GLRA3 SLC45A2 SLC24A1 | 8.12e-04 | 793 | 63 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 8.58e-04 | 59 | 63 | 3 | GO:0008374 | |
| GeneOntologyMolecularFunction | azole transmembrane transporter activity | 8.70e-04 | 14 | 63 | 2 | GO:1901474 | |
| GeneOntologyMolecularFunction | glycine binding | 8.70e-04 | 14 | 63 | 2 | GO:0016594 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 9.24e-04 | 238 | 63 | 5 | GO:0016747 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 9.45e-04 | 61 | 63 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | antiporter activity | 9.49e-04 | 138 | 63 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 1.62e-03 | 19 | 63 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 1.79e-03 | 20 | 63 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 2.17e-03 | 22 | 63 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.54e-03 | 86 | 63 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 2.80e-03 | 25 | 63 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.21e-03 | 459 | 63 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.51e-03 | 28 | 63 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 4.03e-03 | 30 | 63 | 2 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 4.03e-03 | 30 | 63 | 2 | GO:0097472 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 4.23e-03 | 103 | 63 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 4.86e-03 | 33 | 63 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 5.76e-03 | 36 | 63 | 2 | GO:0090482 | |
| GeneOntologyMolecularFunction | channel activity | 6.15e-03 | 525 | 63 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.20e-03 | 526 | 63 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.32e-03 | 119 | 63 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.24e-03 | 125 | 63 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 7.78e-03 | 42 | 63 | 2 | GO:0042887 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 8.14e-03 | 43 | 63 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 8.14e-03 | 43 | 63 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.09e-02 | 50 | 63 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.13e-02 | 51 | 63 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.21e-02 | 151 | 63 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 1.31e-02 | 55 | 63 | 2 | GO:0017046 | |
| GeneOntologyMolecularFunction | cytokine binding | 1.34e-02 | 157 | 63 | 3 | GO:0019955 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ADORA1 OR2B11 GIPR TAS2R3 OR8J2 ADRA2B MCHR1 P2RY1 OR10P1 CXCR4 GLP1R GLRA1 GPR173 AGTR1 GPR84 LTB4R ADGRV1 OR2B6 ADGRA2 | 1.01e-08 | 1395 | 61 | 19 | GO:0007186 |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 1.77e-06 | 124 | 61 | 6 | GO:0007218 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 2.79e-05 | 59 | 61 | 4 | GO:0045777 | |
| GeneOntologyBiologicalProcess | detection of stimulus | ELOVL4 ADORA1 OR2B11 TAS2R3 OR8J2 OR10P1 CXCR4 NAIP ADGRV1 OR2B6 | 4.66e-05 | 722 | 61 | 10 | GO:0051606 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 5.18e-05 | 224 | 61 | 6 | GO:0007204 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 5.65e-05 | 334 | 61 | 7 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 5.65e-05 | 334 | 61 | 7 | GO:0001894 | |
| GeneOntologyBiologicalProcess | sensory perception | ADORA1 OR2B11 TAS2R3 OR8J2 MAP1A OR10P1 CXCR4 GLRA1 SLC45A2 ADGRV1 SLC24A1 OR2B6 | 5.99e-05 | 1072 | 61 | 12 | GO:0007600 |
| GeneOntologyBiologicalProcess | neuron cellular homeostasis | 1.12e-04 | 84 | 61 | 4 | GO:0070050 | |
| GeneOntologyBiologicalProcess | intracellular sphingolipid homeostasis | 1.28e-04 | 6 | 61 | 2 | GO:0090156 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ADORA1 KCNH6 SLC26A8 MCHR1 P2RY1 SLC24A2 CXCR4 SLC15A4 GLP1R GLRA1 AGTR1 GLRA3 SLC24A1 | 1.56e-04 | 1374 | 61 | 13 | GO:0006811 |
| GeneOntologyBiologicalProcess | negative regulation of sphingolipid biosynthetic process | 1.79e-04 | 7 | 61 | 2 | GO:0090155 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.97e-04 | 286 | 61 | 6 | GO:0007188 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.99e-04 | 547 | 61 | 8 | GO:0003012 | |
| GeneOntologyBiologicalProcess | calcium ion import | 2.03e-04 | 98 | 61 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | behavior | ADORA1 MFSD2A ABCA2 MCHR1 MAP1A P2RY1 SLC24A2 GLP1R GLRA1 AGTR1 | 2.62e-04 | 891 | 61 | 10 | GO:0007610 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 2.65e-04 | 302 | 61 | 6 | GO:0022604 | |
| GeneOntologyBiologicalProcess | negative regulation of amine transport | 2.79e-04 | 43 | 61 | 3 | GO:0051953 | |
| GeneOntologyBiologicalProcess | circulatory system process | 2.85e-04 | 733 | 61 | 9 | GO:0003013 | |
| GeneOntologyBiologicalProcess | long-term synaptic depression | 2.99e-04 | 44 | 61 | 3 | GO:0060292 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 3.02e-04 | 582 | 61 | 8 | GO:0050906 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 3.87e-04 | 48 | 61 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 3.87e-04 | 48 | 61 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | negative regulation of norepinephrine secretion | 4.65e-04 | 11 | 61 | 2 | GO:0010700 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 5.29e-04 | 344 | 61 | 6 | GO:0003018 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | ADORA1 ABCA2 MAP1A P2RY1 ORMDL2 SLC24A2 GLP1R SLC45A2 SLC24A1 MSTN | 5.60e-04 | 981 | 61 | 10 | GO:0019725 |
| GeneOntologyBiologicalProcess | response to dexamethasone | 5.79e-04 | 55 | 61 | 3 | GO:0071548 | |
| GeneOntologyBiologicalProcess | G protein-coupled purinergic receptor signaling pathway | 6.57e-04 | 13 | 61 | 2 | GO:0035588 | |
| GeneOntologyBiologicalProcess | G protein-coupled adenosine receptor signaling pathway | 6.57e-04 | 13 | 61 | 2 | GO:0001973 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 7.11e-04 | 59 | 61 | 3 | GO:0045761 | |
| GeneOntologyBiologicalProcess | regulation of respiratory gaseous exchange by nervous system process | 7.65e-04 | 14 | 61 | 2 | GO:0002087 | |
| GeneOntologyBiologicalProcess | organic anion transport | 7.90e-04 | 515 | 61 | 7 | GO:0015711 | |
| GeneOntologyBiologicalProcess | neutral lipid biosynthetic process | 8.61e-04 | 63 | 61 | 3 | GO:0046460 | |
| GeneOntologyBiologicalProcess | acylglycerol biosynthetic process | 8.61e-04 | 63 | 61 | 3 | GO:0046463 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 8.73e-04 | 144 | 61 | 4 | GO:0060291 | |
| GeneOntologyBiologicalProcess | azole transmembrane transport | 8.81e-04 | 15 | 61 | 2 | GO:0045117 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 8.96e-04 | 145 | 61 | 4 | GO:0045833 | |
| GeneOntologyBiologicalProcess | organic cation transport | 8.96e-04 | 145 | 61 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 9.44e-04 | 65 | 61 | 3 | GO:0072348 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ZDHHC2 PIGY ELOVL4 ERGIC1 MFSD2A UBXN4 RETREG2 PTCHD3 MBOAT7 ORMDL2 TMEM68 DGAT2L6 | 4.88e-04 | 1293 | 64 | 12 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ZDHHC2 PIGY ELOVL4 ERGIC1 MFSD2A UBXN4 RETREG2 PTCHD3 MBOAT7 ORMDL2 TMEM68 DGAT2L6 | 5.09e-04 | 1299 | 64 | 12 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | ZDHHC2 PIGY ELOVL4 ERGIC1 MFSD2A UBXN4 RETREG2 PTCHD3 MBOAT7 ORMDL2 TMEM68 DGAT2L6 | 6.16e-04 | 1327 | 64 | 12 | GO:0042175 |
| Domain | GPCR_Rhodpsn | ADORA1 OR2B11 TAS2R3 ADRA2B MCHR1 P2RY1 OR10P1 CXCR4 GPR173 AGTR1 GPR84 LTB4R OR2B6 | 3.45e-07 | 692 | 62 | 13 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | ADORA1 OR2B11 ADRA2B MCHR1 P2RY1 OR10P1 CXCR4 GPR173 AGTR1 GPR84 LTB4R OR2B6 | 1.72e-06 | 670 | 62 | 12 | IPR017452 |
| Domain | 7tm_1 | ADORA1 OR2B11 ADRA2B MCHR1 P2RY1 OR10P1 CXCR4 GPR173 AGTR1 GPR84 LTB4R OR2B6 | 1.91e-06 | 677 | 62 | 12 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | ADORA1 OR2B11 ADRA2B MCHR1 P2RY1 OR10P1 CXCR4 GPR173 AGTR1 GPR84 LTB4R OR2B6 | 2.16e-06 | 685 | 62 | 12 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | ADORA1 OR2B11 ADRA2B MCHR1 P2RY1 OR10P1 CXCR4 GPR173 AGTR1 GPR84 LTB4R OR2B6 | 2.37e-06 | 691 | 62 | 12 | PS50262 |
| Domain | G_PROTEIN_RECEP_F2_1 | 9.20e-06 | 40 | 62 | 4 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 9.20e-06 | 40 | 62 | 4 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 9.20e-06 | 40 | 62 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.26e-05 | 50 | 62 | 4 | PS00650 | |
| Domain | 7tm_2 | 2.26e-05 | 50 | 62 | 4 | PF00002 | |
| Domain | GPCR_2-like | 4.67e-05 | 60 | 62 | 4 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 4.67e-05 | 60 | 62 | 4 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.99e-05 | 61 | 62 | 4 | PS50261 | |
| Domain | Glycine_rcpt_A | 6.48e-05 | 4 | 62 | 2 | IPR008127 | |
| Domain | MFS_dom | 8.22e-05 | 134 | 62 | 5 | IPR020846 | |
| Domain | HRM | 1.08e-04 | 28 | 62 | 3 | PF02793 | |
| Domain | K/Na/Ca-exchanger | 1.08e-04 | 5 | 62 | 2 | IPR004481 | |
| Domain | GPCR_2_secretin-like_CS | 1.94e-04 | 34 | 62 | 3 | IPR017983 | |
| Domain | CXCR4/ACKR2 | 2.25e-04 | 7 | 62 | 2 | IPR001277 | |
| Domain | NaCa_Exmemb | 3.85e-04 | 9 | 62 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 3.85e-04 | 9 | 62 | 2 | PF01699 | |
| Domain | MFS | 2.14e-03 | 77 | 62 | 3 | IPR011701 | |
| Domain | MFS_1 | 2.14e-03 | 77 | 62 | 3 | PF07690 | |
| Domain | GABAA/Glycine_rcpt | 2.62e-03 | 23 | 62 | 2 | IPR006028 | |
| Domain | HormR | 3.10e-03 | 25 | 62 | 2 | SM00008 | |
| Domain | GPS | 5.68e-03 | 34 | 62 | 2 | SM00303 | |
| Domain | GPS | 6.01e-03 | 35 | 62 | 2 | PF01825 | |
| Domain | 7TM_GPCR_Srsx | 6.14e-03 | 112 | 62 | 3 | SM01381 | |
| Domain | GPS | 6.35e-03 | 36 | 62 | 2 | PS50221 | |
| Domain | PTPc | 6.35e-03 | 36 | 62 | 2 | SM00194 | |
| Domain | GPS | 6.70e-03 | 37 | 62 | 2 | IPR000203 | |
| Domain | TYR_PHOSPHATASE_PTP | 7.42e-03 | 39 | 62 | 2 | PS50055 | |
| Domain | PTPase_domain | 8.18e-03 | 41 | 62 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 8.18e-03 | 41 | 62 | 2 | PF00102 | |
| Domain | Neurotransmitter_ion_chnl_CS | 9.79e-03 | 45 | 62 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 1.02e-02 | 46 | 62 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 1.06e-02 | 47 | 62 | 2 | PF02931 | |
| Domain | Neur_channel | 1.06e-02 | 47 | 62 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.06e-02 | 47 | 62 | 2 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 1.06e-02 | 47 | 62 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.06e-02 | 47 | 62 | 2 | IPR006029 | |
| Domain | - | 1.06e-02 | 47 | 62 | 2 | 2.70.170.10 | |
| Pathway | WP_GPCRS_NONODORANT | ADORA1 GIPR TAS2R3 ADRA2B MCHR1 P2RY1 CXCR4 GLP1R AGTR1 LTB4R | 3.13e-08 | 266 | 51 | 10 | MM15843 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | ADORA1 GIPR ADRA2B MCHR1 P2RY1 GLP1R GLRA1 AGTR1 GLRA3 LTB4R | 3.86e-08 | 272 | 51 | 10 | M13380 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.33e-07 | 260 | 51 | 9 | M39397 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | ADORA1 GIPR TAS2R3 ADRA2B MCHR1 P2RY1 CXCR4 GLP1R AGTR1 LTB4R | 2.62e-06 | 430 | 51 | 10 | MM15160 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | ADORA1 GIPR TAS2R3 ADRA2B MCHR1 P2RY1 CXCR4 GLP1R AGTR1 LTB4R | 5.06e-06 | 463 | 51 | 10 | M507 |
| Pathway | WP_NUCLEOTIDE_GPCRS | 7.21e-06 | 11 | 51 | 3 | M39422 | |
| Pathway | WP_NUCLEOTIDE_GPCRS | 9.59e-06 | 12 | 51 | 3 | MM15953 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | ADORA1 GIPR TAS2R3 ADRA2B MCHR1 P2RY1 CXCR4 GLP1R AGTR1 GPR84 LTB4R | 1.53e-05 | 646 | 51 | 11 | MM14962 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | ADORA1 GIPR TAS2R3 ADRA2B MCHR1 P2RY1 CXCR4 GLP1R AGTR1 GPR84 LTB4R | 3.31e-05 | 702 | 51 | 11 | M746 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.73e-04 | 330 | 51 | 7 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.83e-04 | 333 | 51 | 7 | MM14963 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 5.44e-04 | 186 | 51 | 5 | MM15994 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.17e-04 | 108 | 51 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.39e-04 | 109 | 51 | 4 | MM15074 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 6.91e-04 | 11 | 51 | 2 | M27336 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 9.76e-04 | 13 | 51 | 2 | MM15078 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 1.49e-03 | 16 | 51 | 2 | M6786 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 1.49e-03 | 16 | 51 | 2 | MM15050 | |
| Pubmed | 4.60e-08 | 179 | 65 | 7 | 18577758 | ||
| Pubmed | 9.83e-08 | 200 | 65 | 7 | 18240029 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 19766644 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 14966573 | ||
| Pubmed | Characterization of the glycinergic input to bipolar cells of the mouse retina. | 3.44e-06 | 2 | 65 | 2 | 16420443 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 34168617 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 22112810 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 21486794 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 18500760 | ||
| Pubmed | Phosphorylation of α3 glycine receptors induces a conformational change in the glycine-binding site. | 3.44e-06 | 2 | 65 | 2 | 23834509 | |
| Pubmed | Investigating GIPR (ant)agonism: A structural analysis of GIP and its receptor. | 3.44e-06 | 2 | 65 | 2 | 33891864 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 24866833 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 35065096 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 29351421 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 17717280 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 27020250 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 24967820 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 36177761 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 21095180 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 29157578 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 17187081 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 30462524 | ||
| Pubmed | Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells. | 3.44e-06 | 2 | 65 | 2 | 36774542 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 32579955 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 21673098 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 15111503 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 19401425 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 34122340 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 10662833 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 27179756 | ||
| Pubmed | Heteromeric association creates a P2Y-like adenosine receptor. | 3.44e-06 | 2 | 65 | 2 | 11390975 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 19959465 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 22412906 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 27677765 | ||
| Pubmed | Insulin action in the double incretin receptor knockout mouse. | 3.44e-06 | 2 | 65 | 2 | 17977951 | |
| Pubmed | A multidimensional coding architecture of the vagal interoceptive system. | 4.98e-06 | 18 | 65 | 3 | 35296859 | |
| Pubmed | Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma. | 1.03e-05 | 3 | 65 | 2 | 32896760 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 20972533 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 19386626 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 24939431 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 21540554 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 21068156 | ||
| Pubmed | Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit. | 1.03e-05 | 3 | 65 | 2 | 17154252 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 17920294 | ||
| Pubmed | Treatment of type 2 diabetes with the designer cytokine IC7Fc. | 1.03e-05 | 3 | 65 | 2 | 31554967 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 24165127 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 1.92e-05 | 84 | 65 | 4 | 15203218 | |
| Pubmed | TCF1 links GIPR signaling to the control of beta cell function and survival. | 2.06e-05 | 4 | 65 | 2 | 26642437 | |
| Pubmed | Glycinergic input of widefield, displaced amacrine cells of the mouse retina. | 2.06e-05 | 4 | 65 | 2 | 19528249 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 9051263 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 21486797 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 26631410 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 9268704 | ||
| Pubmed | A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. | 2.06e-05 | 4 | 65 | 2 | 25485909 | |
| Pubmed | Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers. | 2.06e-05 | 4 | 65 | 2 | 28883437 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 34069563 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 24927416 | ||
| Pubmed | Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery. | 2.06e-05 | 4 | 65 | 2 | 29203510 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 34844019 | ||
| Pubmed | GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion. | 3.43e-05 | 5 | 65 | 2 | 17681422 | |
| Pubmed | Expression of potassium-dependent sodium-calcium exchanger in the murine lens. | 3.43e-05 | 5 | 65 | 2 | 29128492 | |
| Pubmed | Developmental regulation of glycine receptors at efferent synapses of the murine cochlea. | 3.43e-05 | 5 | 65 | 2 | 21850450 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 27839908 | ||
| Pubmed | Native glycine receptor subtypes and their physiological roles. | 3.43e-05 | 5 | 65 | 2 | 18721822 | |
| Pubmed | Sensory Neurons that Detect Stretch and Nutrients in the Digestive System. | 3.43e-05 | 5 | 65 | 2 | 27238020 | |
| Pubmed | Sodium/calcium exchanger expression in the mouse and rat olfactory systems. | 5.13e-05 | 6 | 65 | 2 | 17311327 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 28862946 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 22933106 | ||
| Pubmed | Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex. | 7.18e-05 | 7 | 65 | 2 | 22988142 | |
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 28092375 | ||
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 35705049 | ||
| Pubmed | Strain background effects and genetic modifiers of hearing in mice. | 1.87e-04 | 11 | 65 | 2 | 16579977 | |
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 12935356 | ||
| Pubmed | An Airway Protection Program Revealed by Sweeping Genetic Control of Vagal Afferents. | 2.65e-04 | 13 | 65 | 2 | 32259485 | |
| Pubmed | Alternative splice variants encoding unstable protein domains exist in the human brain. | 2.65e-04 | 13 | 65 | 2 | 15491607 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 3.20e-04 | 697 | 65 | 7 | 28298427 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 3.42e-04 | 499 | 65 | 6 | 22810586 | |
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 21045126 | ||
| Pubmed | Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex. | 4.06e-04 | 16 | 65 | 2 | 25425146 | |
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 31669249 | ||
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 38448588 | ||
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 4.59e-04 | 17 | 65 | 2 | 19727691 | |
| Pubmed | Oligodendrocyte precursors migrate along vasculature in the developing nervous system. | 6.39e-04 | 20 | 65 | 2 | 26798014 | |
| Pubmed | 6.39e-04 | 20 | 65 | 2 | 29084951 | ||
| Pubmed | 7.06e-04 | 21 | 65 | 2 | 32731332 | ||
| Pubmed | 7.06e-04 | 21 | 65 | 2 | 15452121 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 7.63e-04 | 95 | 65 | 3 | 16754659 | |
| Pubmed | 1.00e-03 | 25 | 65 | 2 | 28706241 | ||
| Pubmed | Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins. | 1.00e-03 | 25 | 65 | 2 | 28154160 | |
| Pubmed | 1.17e-03 | 27 | 65 | 2 | 19723784 | ||
| Pubmed | Conditionals by inversion provide a universal method for the generation of conditional alleles. | 1.17e-03 | 27 | 65 | 2 | 23918385 | |
| Pubmed | Reconstruction of phrenic neuron identity in embryonic stem cell-derived motor neurons. | 1.17e-03 | 27 | 65 | 2 | 24496616 | |
| Pubmed | Perinatal survivin is essential for the establishment of pancreatic beta cell mass in mice. | 1.26e-03 | 28 | 65 | 2 | 19644667 | |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 1.35e-03 | 29 | 65 | 2 | 15203201 | |
| Pubmed | 1.35e-03 | 29 | 65 | 2 | 17339028 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.75e-03 | 33 | 65 | 2 | 25713288 | |
| Pubmed | 1.86e-03 | 34 | 65 | 2 | 25505242 | ||
| Interaction | VKORC1L1 interactions | 1.14e-05 | 99 | 60 | 5 | int:VKORC1L1 | |
| GeneFamily | Solute carriers | SLC7A9 SLC26A8 SLC24A2 SLC22A14 SLC15A4 SLC19A3 SLC45A2 SLC24A1 | 9.96e-06 | 395 | 49 | 8 | 752 |
| GeneFamily | Glycine receptors | 7.16e-05 | 5 | 49 | 2 | 868 | |
| GeneFamily | Glucagon receptor family | 1.07e-04 | 6 | 49 | 2 | 269 | |
| GeneFamily | Cyclin dependent kinases | 2.24e-03 | 26 | 49 | 2 | 496 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | ZDHHC2 MFSD2A MAP1A ORMDL2 PLXNC1 PAPPA CDK11B GLB1L2 ADGRV1 | 9.41e-06 | 493 | 60 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_200 | 1.70e-05 | 18 | 60 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ZDHHC2 MFSD2A ABCA2 MAP1A ORMDL2 PLXNC1 CXCR4 GLRA1 PAPPA CDK11B ADGRV1 TMEM68 | 1.72e-05 | 989 | 60 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_200 | 4.16e-05 | 24 | 60 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | ZDHHC2 MFSD2A CSF1R MAP1A ORMDL2 PLXNC1 GLP1R PAPPA CDK11B GLB1L2 ADGRV1 | 8.44e-05 | 983 | 60 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200 | 1.19e-04 | 170 | 60 | 5 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_200 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-07 | 192 | 64 | 6 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-06 | 153 | 64 | 5 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-06 | 153 | 64 | 5 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-06 | 175 | 64 | 5 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.47e-06 | 176 | 64 | 5 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.47e-06 | 176 | 64 | 5 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.62e-06 | 183 | 64 | 5 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 191 | 64 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.78e-06 | 194 | 64 | 5 | 024568d8a862f0fe4da1f66a58c6e71f0e8279f3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.00e-06 | 195 | 64 | 5 | 9cfbdb528088ad0ab100c7431c7d8f140a846de8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.00e-06 | 195 | 64 | 5 | 66f3b3e15eaa21bc7cf2f204cac81de1a160a748 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.00e-06 | 195 | 64 | 5 | bbf5f79be4fcea754328f1af7ee5625075248100 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-06 | 197 | 64 | 5 | 61bda9b5102fdbce902bb976d1aa62f2c799d2fb | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-06 | 197 | 64 | 5 | e0fc098bfb5a8b7824ae339f3adda30f78360d0b | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.69e-06 | 198 | 64 | 5 | 2e07e62ed230763a6859a8ce19429b5ca8b365a6 | |
| ToppCell | distal-3-Hematologic-Myeloid_Dendritic_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.69e-06 | 198 | 64 | 5 | 8e5ac110278461af6eceec1e04de02df8430d1d7 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_2|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.69e-06 | 198 | 64 | 5 | 3b0143efc33486c1e340ca57981c83cf7e2cad29 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.69e-06 | 198 | 64 | 5 | 984b3753fabd5553f6f364f90a422b035e421535 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_2-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.69e-06 | 198 | 64 | 5 | f254287e13328a8f3b14bf4e44736041ad35593e | |
| ToppCell | distal-2-Hematologic-Myeloid_Dendritic_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.93e-06 | 199 | 64 | 5 | 86ee039189c75e66b97453c20a34d7fb5a31e51d | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.93e-06 | 199 | 64 | 5 | 78e70852acda95d2c770cdd539a46b291f929a78 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-05 | 148 | 64 | 4 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 150 | 64 | 4 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 150 | 64 | 4 | 8645b9c7f9511ed6cc9afe04440c2873a3094150 | |
| ToppCell | control-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.97e-05 | 153 | 64 | 4 | 87dc61f7dd76b42c4d1e14fd33958b6a02116bc8 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-05 | 154 | 64 | 4 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.21e-05 | 56 | 64 | 3 | af55596513ddbe60b08648b27e41a7b65e3da58c | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.33e-05 | 155 | 64 | 4 | 08295584395e8d9cfc1b1648f98754b3ac53e587 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.70e-05 | 157 | 64 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.34e-05 | 165 | 64 | 4 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.78e-05 | 167 | 64 | 4 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.00e-04 | 168 | 64 | 4 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 1.05e-04 | 170 | 64 | 4 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 171 | 64 | 4 | 355a27ea88410a84210f7e4298c7c4f90cf2f8a9 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.10e-04 | 172 | 64 | 4 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 178 | 64 | 4 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | Dendritic_Cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-04 | 178 | 64 | 4 | 61ce3ec64c4cffceac08412e20c26e9c90ab8197 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 178 | 64 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 1.33e-04 | 181 | 64 | 4 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | Control-Myeloid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 181 | 64 | 4 | 25170e5285996cc80337d5f86a0255569861ae77 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 183 | 64 | 4 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.42e-04 | 184 | 64 | 4 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 185 | 64 | 4 | eb78614c4acf8d2ce7874d7e51e16997b76127ef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-04 | 186 | 64 | 4 | c7e2134454ab5d0885050dd1bb3c3bd15bf497ac | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.51e-04 | 187 | 64 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 187 | 64 | 4 | 4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | 0a874578f5692a896ea3071a17d87cdeb242fb11 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | Severe-MAIT|World / Disease group and Cell class | 1.61e-04 | 190 | 64 | 4 | 7a92e0d6a021be23125495927b8571e25c83204a | |
| ToppCell | (2)_Dendritic_Cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.61e-04 | 190 | 64 | 4 | 5163a5be95fb6c2609bfa3d69166af172f74e724 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 192 | 64 | 4 | 5692bd57093852d442400383850f416c497dcc7d | |
| ToppCell | moderate-Myeloid-Neutrophil|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.67e-04 | 192 | 64 | 4 | 8105408400dac5dcb0ce62b558433257559c9f09 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.71e-04 | 193 | 64 | 4 | 704378de39e1b6f108ab5b0ecbd594d414ec8ae4 | |
| ToppCell | Dendritic_Cells|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-04 | 193 | 64 | 4 | 7792eb6e247af2d7a8f80476f37dcd880922d625 | |
| ToppCell | (2)_MNPs|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.74e-04 | 194 | 64 | 4 | 9cd64e325ec233da82c463b09262efe93d2a92ee | |
| ToppCell | medial-2-Hematologic-EREG+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.74e-04 | 194 | 64 | 4 | b2b4e4c3ac0df0d9f17b930ffb60c0fd85b3dd78 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 64 | 4 | ba529c051f248d29f4222f4bc9801ba233859093 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 64 | 4 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-04 | 194 | 64 | 4 | 36f8ae4f2b3bf802f6ff0e9fc79e7f170f96ae8b | |
| ToppCell | medial-Hematologic-EREG+_Dendritic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.74e-04 | 194 | 64 | 4 | 15f3b6b6579e388d0820f05e93a77ee1634bd6c3 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 194 | 64 | 4 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | medial-Hematologic-EREG+_Dendritic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.74e-04 | 194 | 64 | 4 | 1f3d22292d2691f93aa7b6770f5c250a33db3cc0 | |
| ToppCell | (2)_Mono_macro|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.74e-04 | 194 | 64 | 4 | 7c05525614ee8cdfcbf22cce9146a8e73af7d14e | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.74e-04 | 194 | 64 | 4 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.77e-04 | 195 | 64 | 4 | 54a404ee1b97d0659fcffafb20d11f878ed453d4 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.77e-04 | 195 | 64 | 4 | c0d1ecb378bb482a8e08d7065fcca07a65687dac | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | e10b21e4dba4483efc4c82d6e395524246ca14a8 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 195 | 64 | 4 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.77e-04 | 195 | 64 | 4 | 35a5302b8b3e76bc92dc38979400c979f0e86550 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 195 | 64 | 4 | 7dd0cb8f3753fe761fac200cbd161708b6528c51 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | 9ab3c5b0fb12d406408122a535b717bfe184bbcf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | 21263d138c81f6a0219f2cd93126cfafd35732b2 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus,_TRN+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.79e-04 | 76 | 64 | 3 | 14350e0e8fc43531f33f6ed4e583e94a13d1dde5 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus,_TRN+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.79e-04 | 76 | 64 | 3 | 539f0076d0571be049c35541a3b281f86ddbecd6 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.79e-04 | 76 | 64 | 3 | 492cdcbc577a9334af8e4ded469da17bc7e79025 | |
| ToppCell | distal-Hematologic-EREG+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-04 | 196 | 64 | 4 | c17bb7b3992bfec194bfa310f201a5c64b35868e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 196 | 64 | 4 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 196 | 64 | 4 | c2bbb48c4aa979b03cb6f4ce9f351f492977c992 | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-04 | 196 | 64 | 4 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | Bronchial_Biopsy-Immune-Dendritic_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.81e-04 | 196 | 64 | 4 | bd828596c5b3fd5e4156f555e532f3de99d32f92 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 196 | 64 | 4 | 5146976881d79642ebe5dcbcf89e0252713a9ef2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 196 | 64 | 4 | 64c2abc0087bf2ae547932377f3662e3be1cc63e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 196 | 64 | 4 | ebac1d6af7a5732707d82d01285c086b19d8ae62 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-04 | 196 | 64 | 4 | 8862964090f9a679a548103bfbb12e91295aae62 | |
| ToppCell | medial-2-Hematologic-Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.84e-04 | 197 | 64 | 4 | fbff79d6ece1605126ae0caa0c71253ea557779c | |
| ToppCell | medial-Hematologic-Classical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.84e-04 | 197 | 64 | 4 | 3960eac4b6753e3294e13901f6ea13d894275c8d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 197 | 64 | 4 | d14e1f2ba94240c61eac435db43508a224d606a8 | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.84e-04 | 197 | 64 | 4 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | medial-Hematologic-Classical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.84e-04 | 197 | 64 | 4 | ae2b51d4e91126ee0a0f69c040297c2a78ce27dd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-04 | 197 | 64 | 4 | d568354aff89ac84dd06360f19100ef578a041ed | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.86e-04 | 77 | 64 | 3 | 10969743351c49a1d6d8ae1ef93098e7786ca3fe | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 77 | 64 | 3 | 557f7518e9a89d99f3f2474720deb9cde10e1054 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-04 | 198 | 64 | 4 | 59214e34b077dffa989c48635fdef143f57f1320 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 198 | 64 | 4 | 54c8aa47040bc4977eed382514fc4ceae03f54f8 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.88e-04 | 198 | 64 | 4 | 7f7024b26337ae2bc7f57c3274a7dfdaaa64ab7c | |
| ToppCell | NS-critical-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-04 | 198 | 64 | 4 | 72d51284d267f102c26f0ae8279ee9e11e69c7e3 | |
| ToppCell | Bronchial_Biopsy-Immune|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.88e-04 | 198 | 64 | 4 | 1c30eebbe16a331039a9063b93774b5daf518b6e | |
| Computational | Genes in the cancer module 367. | 2.37e-06 | 29 | 36 | 4 | MODULE_367 | |
| Computational | Genes in the cancer module 27. | 1.47e-04 | 355 | 36 | 7 | MODULE_27 | |
| Computational | Genes in the cancer module 146. | 3.57e-04 | 102 | 36 | 4 | MODULE_146 | |
| Computational | AcetylCholine receptors. | 9.68e-04 | 14 | 36 | 2 | MODULE_328 | |
| Computational | Neurotransmitter (GABA) receptor. | 1.11e-03 | 15 | 36 | 2 | MODULE_215 | |
| Computational | Genes in the cancer module 267. | 1.11e-03 | 15 | 36 | 2 | MODULE_267 | |
| Drug | Theobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 1.29e-06 | 196 | 64 | 7 | 4958_UP | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.43e-06 | 199 | 64 | 7 | 4067_UP | |
| Drug | guanethidine | 1.66e-05 | 113 | 64 | 5 | CID000003518 | |
| Drug | prazosin | 1.71e-05 | 193 | 64 | 6 | CID000004893 | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 5665_UP | |
| Drug | DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 2877_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 2628_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 2670_UP | |
| Drug | monastrol; Up 200; 20uM; MCF7; HG-U133A | 1.92e-05 | 197 | 64 | 6 | 605_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 2146_DN | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 3670_UP | |
| Drug | Nimodipine [66085-59-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 6320_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 6783_UP | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; PC3; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 5794_UP | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 6069_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 2747_UP | |
| Drug | S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 6459_UP | |
| Drug | Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 6092_UP | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 5730_UP | |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 4377_UP | |
| Drug | L000058 | 2.33e-05 | 20 | 64 | 3 | CID004469580 | |
| Drug | propanethiol | 2.33e-05 | 20 | 64 | 3 | CID000007848 | |
| Drug | CGP 35348 | 2.80e-05 | 62 | 64 | 4 | CID000107699 | |
| Drug | enflurane | 4.04e-05 | 68 | 64 | 4 | CID000003226 | |
| Drug | 2-chloro-N6-cyclopentyladenosine | 4.11e-05 | 24 | 64 | 3 | CID000001547 | |
| Drug | iso-THAZ | 4.65e-05 | 4 | 64 | 2 | CID003047783 | |
| Drug | protostrychnine | 4.65e-05 | 4 | 64 | 2 | CID005320746 | |
| Drug | 7-nitroindoline | 4.65e-05 | 4 | 64 | 2 | CID013566747 | |
| Drug | 2-(phosphonomethyl)phenylalanine | 4.65e-05 | 4 | 64 | 2 | CID000383689 | |
| Drug | SC-49648 | 4.65e-05 | 4 | 64 | 2 | CID000195696 | |
| Drug | akuammiline | 4.65e-05 | 4 | 64 | 2 | CID005367018 | |
| Drug | 4-NA | 4.65e-05 | 4 | 64 | 2 | CID006102690 | |
| Drug | NSC381080 | 4.65e-05 | 4 | 64 | 2 | CID000165497 | |
| Drug | N-methyl-THIP | 4.65e-05 | 4 | 64 | 2 | CID000134373 | |
| Drug | SC-48981 | 4.65e-05 | 4 | 64 | 2 | CID000126573 | |
| Drug | SC-50132 | 4.65e-05 | 4 | 64 | 2 | CID000195719 | |
| Drug | SR 42641 | 4.65e-05 | 4 | 64 | 2 | CID000129049 | |
| Drug | P2-N | 4.66e-05 | 25 | 64 | 3 | CID011987828 | |
| Drug | ifenprodil | 4.79e-05 | 71 | 64 | 4 | CID000003689 | |
| Drug | azetidine-3-carboxylic acid | 7.74e-05 | 5 | 64 | 2 | CID000093192 | |
| Drug | Lindane | 7.74e-05 | 5 | 64 | 2 | DB00431 | |
| Drug | Cao C | 7.74e-05 | 5 | 64 | 2 | CID000166617 | |
| Drug | oxanilide | 7.74e-05 | 5 | 64 | 2 | CID000069288 | |
| Drug | iso-THAO | 7.74e-05 | 5 | 64 | 2 | CID000127199 | |
| Drug | ALX1393 | 7.74e-05 | 5 | 64 | 2 | CID016078939 | |
| Drug | pleiocarpamine | 7.74e-05 | 5 | 64 | 2 | CID000558637 | |
| Drug | mafoprazine | 7.74e-05 | 5 | 64 | 2 | CID000071241 | |
| Drug | gevotroline | 7.74e-05 | 5 | 64 | 2 | CID000060546 | |
| Drug | doxazosin | 8.83e-05 | 83 | 64 | 4 | CID000003157 | |
| Drug | urethane | 1.14e-04 | 169 | 64 | 5 | CID000005641 | |
| Drug | THAZ | 1.16e-04 | 6 | 64 | 2 | CID000171289 | |
| Drug | mV GABA | 1.16e-04 | 6 | 64 | 2 | CID000128435 | |
| Drug | caged glycine | 1.16e-04 | 6 | 64 | 2 | CID000192642 | |
| Drug | brometone | 1.16e-04 | 6 | 64 | 2 | CID000006424 | |
| Drug | minaxolone | 1.16e-04 | 6 | 64 | 2 | CID000071960 | |
| Drug | thiomuscimol | 1.16e-04 | 6 | 64 | 2 | CID000005448 | |
| Drug | thio-THIP | 1.16e-04 | 6 | 64 | 2 | CID000656720 | |
| Drug | AC1L90PQ | 1.16e-04 | 6 | 64 | 2 | CID000436036 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.30e-04 | 174 | 64 | 5 | 6085_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.34e-04 | 175 | 64 | 5 | 3746_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 1.53e-04 | 180 | 64 | 5 | 5950_UP | |
| Drug | ICS-205,930 | 1.54e-04 | 37 | 64 | 3 | CID000005595 | |
| Drug | alpha-EMTBL | 1.62e-04 | 7 | 64 | 2 | CID000128423 | |
| Drug | CID189778 | 1.62e-04 | 7 | 64 | 2 | CID000189778 | |
| Drug | propyl methanethiosulfonate | 1.62e-04 | 7 | 64 | 2 | CID000529387 | |
| Drug | thiocolchicoside | 1.62e-04 | 7 | 64 | 2 | CID000072067 | |
| Drug | L-serinamide | 1.62e-04 | 7 | 64 | 2 | CID000101138 | |
| Drug | Boc-glycine | 1.62e-04 | 7 | 64 | 2 | CID000078288 | |
| Drug | PK 8165 | 1.62e-04 | 7 | 64 | 2 | CID000071219 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 1.74e-04 | 185 | 64 | 5 | 5908_UP | |
| Drug | LIGA20 | 1.80e-04 | 39 | 64 | 3 | CID006441213 | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; PC3; HT_HG-U133A | 1.96e-04 | 190 | 64 | 5 | 4663_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.01e-04 | 191 | 64 | 5 | 4302_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.01e-04 | 191 | 64 | 5 | 3392_UP | |
| Drug | cyclothiazide | 2.04e-04 | 103 | 64 | 4 | CID000002910 | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 2482_UP | |
| Drug | indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A | 2.11e-04 | 193 | 64 | 5 | 262_UP | |
| Drug | AC1OC6D1 | 2.11e-04 | 104 | 64 | 4 | CID006368594 | |
| Drug | NRA 0045 | 2.15e-04 | 8 | 64 | 2 | ctd:C106996 | |
| Drug | WT702 | 2.15e-04 | 8 | 64 | 2 | CID000089643 | |
| Drug | isostrychnine | 2.15e-04 | 8 | 64 | 2 | CID000264626 | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 3680_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 5609_UP | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 4951_UP | |
| Drug | Luteolin [491-70-3]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 3379_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 7309_UP | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; HL60; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 2907_UP | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 3530_DN | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 4167_DN | |
| Drug | Prednicarbate [73771-04-7]; Up 200; 8.2uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 5119_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 3800_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; HL60; HG-U133A | 2.27e-04 | 196 | 64 | 5 | 1566_UP | |
| Drug | Bretylium tosylate [61-75-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 3394_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 4281_UP | |
| Drug | Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 5622_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 2862_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 4288_UP | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 6754_UP | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 4970_UP | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 3380_UP | |
| Disease | conotruncal heart malformations | 9.92e-05 | 114 | 62 | 4 | MONDO_0016581 | |
| Disease | hypertension (implicated_via_orthology) | 1.55e-04 | 128 | 62 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | Methionine sulfoxide measurement | 2.83e-04 | 12 | 62 | 2 | EFO_0021650 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 4.48e-04 | 15 | 62 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | lung adenocarcinoma (is_marker_for) | 7.72e-04 | 85 | 62 | 3 | DOID:3910 (is_marker_for) | |
| Disease | obesity (is_implicated_in) | 9.41e-04 | 91 | 62 | 3 | DOID:9970 (is_implicated_in) | |
| Disease | Disorder of eye | 1.04e-03 | 212 | 62 | 4 | C0015397 | |
| Disease | myocardial infarction (is_implicated_in) | 1.20e-03 | 99 | 62 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | obesity (is_marker_for) | 1.27e-03 | 101 | 62 | 3 | DOID:9970 (is_marker_for) | |
| Disease | diabetes mellitus (is_implicated_in) | 1.70e-03 | 29 | 62 | 2 | DOID:9351 (is_implicated_in) | |
| Disease | blood viscosity | 1.94e-03 | 31 | 62 | 2 | EFO_0004301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLTILQKWILPFSPI | 1386 | Q13075 | |
| VYVGVWIPALLLTIP | 156 | P61073 | |
| WIPALLLTIPDFIFA | 161 | P61073 | |
| FVWVLPPLLLMVLIY | 186 | P30542 | |
| GAFYIPVALILLITW | 926 | Q96PE1 | |
| FPFLIILTSYTLIWK | 206 | P30556 | |
| LLWSLLLYTTPPTYI | 241 | Q6P575 | |
| PLILYLFALISVTWL | 6106 | Q8WXG9 | |
| VWLIAAVISLPPLIY | 136 | P18089 | |
| APALFVIPWVIVRYL | 266 | P48546 | |
| PVVVTLWYRAPELLL | 596 | P21127 | |
| YIPSLLIVILSWVSF | 261 | O75311 | |
| IWVVSQLYPESIVPI | 256 | Q96HW7 | |
| APIWFRVPYSIISLL | 191 | P43378 | |
| VLLSIPFFSIPVVWT | 36 | Q53FV1 | |
| WLIVVVAISPILFYS | 176 | P47900 | |
| PWLEFPLLVVFLISY | 21 | P58173 | |
| VPYLTSITALVVWLP | 241 | P78559 | |
| YLFLLPIVFPLWLTV | 911 | O60721 | |
| IFDITVGLPVPWLLF | 1011 | O60721 | |
| VPLLFVVPWGIVKYL | 276 | P43220 | |
| PWPTLSISTLYLLFV | 46 | Q9GZR5 | |
| WLILLLVIYTAVFTP | 261 | Q9H252 | |
| VPSTWYFLIVLPVLL | 941 | O60486 | |
| IPAIWFRYDLSPITV | 226 | Q969X5 | |
| WTYLVVLLISIPIGF | 6 | Q96N66 | |
| LSYKVPWPVDIVISL | 801 | Q96RT8 | |
| EFLYPLVPESLTIWV | 786 | Q13219 | |
| SFAPLWPIYILVPVV | 151 | Q9NQS5 | |
| IIFWYVLPVSITVFL | 251 | Q9UHF4 | |
| IWVLSFLLATPVLAY | 141 | Q15722 | |
| WLELPLFVVLLLSYV | 26 | Q5JQS5 | |
| IWSPLLYAVVVSPKV | 126 | Q8NGG1 | |
| TPLAVIAYFLIWFVP | 136 | Q8NA29 | |
| LTLRYPPEVSVIWTF | 396 | P07333 | |
| LTPVVVTLWYRAPEV | 171 | P11802 | |
| WLLPPFLAIVYFCTI | 11 | Q05707 | |
| WIPVYIFLGAIPILL | 21 | Q6ZPD8 | |
| PIPAYLFSWASLIVI | 106 | P82251 | |
| RVLYPASWIVPLFVA | 296 | P82251 | |
| SPWVLAFEIFIPLVL | 21 | Q9BZC7 | |
| ITLLFLLLWSPYIVA | 291 | Q9NS66 | |
| FISITPVWLYARLIP | 241 | Q99705 | |
| VISCYWLFEIPPLIS | 71 | Q9BZP3 | |
| EPLTPVLYLSLWDAL | 386 | Q8IW92 | |
| LVIPFISYIWILPES | 306 | Q9Y267 | |
| IVPVFLALIPYWTVY | 321 | Q8N697 | |
| FPVWTYSYLVLLLPV | 56 | Q9BZV2 | |
| PSSLYSIVWFLSPIL | 66 | Q9UMX9 | |
| LLLIPYPLCSLWVTF | 816 | Q3KNS1 | |
| PSLVRWFYIVVVPID | 1126 | P10586 | |
| PLFWVVLLVYLVTLL | 26 | Q8NGE3 | |
| TLWYLPPLIVSLASY | 186 | Q9NYW6 | |
| VFPIVFPLWITLPDV | 476 | Q9UI40 | |
| ITVGLPLPWLLYTVI | 576 | Q9UI40 | |
| VIPYLETISNLPSLW | 466 | Q96RN1 | |
| YIPSLLIVILSWISF | 256 | P23415 | |
| LWIYLRPVETPTTVF | 156 | O14793 | |
| YIVLLSILLWPLVVY | 211 | Q8NC44 | |
| LLVALLLWPSSVPAY | 6 | Q6UW49 | |
| WVFTPLILLILPYFT | 46 | Q96MH6 | |
| VILPALTLVYFSILW | 741 | Q9UJ98 | |
| YPWVVDRVVFPTITL | 391 | Q8NE00 | |
| LLPITIPVYVFFHLW | 46 | Q3MUY2 | |
| YLRAVSIPVWIILLF | 216 | Q9H330 | |
| PVLLIIYFVSLLAPW | 266 | Q5GH77 | |
| RVLYWIPVVFITLLL | 16 | Q9UIJ5 | |
| IWTLLGTVLYPFLAI | 411 | Q92575 | |
| APTLYLPVLAWVFVL | 166 | Q8NI32 |